Results 31 to 40 of about 3,641 (196)

Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria [PDF]

Malaria Journal
Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns.
Taiwo Ibinaiye, Kunle Rotimi, Ayodeji Balogun, Adaeze Aidenagbon, Chibuzo Oguoma, Christian Rassi, Kevin Baker, Olusola Oresanya, Chuks Nnaji   +8 more
doaj   +2 more sources

Usefulness of seasonal malaria chemoprevention in the Sahel

The Lancet Infectious Diseases, 2023
Seasonal malaria chemoprevention is an important intervention recommended for children aged 3–59 months living in highly seasonal transmission areas of the Sahel subregion of Africa to provide protection against malaria during the rainy season. In The Lancet Infectious Diseases, Colin J Sutherland and colleagues report on the prevalence of Plasmodium ...
Kayiba Kalenda, Nadine, Tshibangu-Kabamba, Evariste, Nakagama, Yu, Kaku, Natsuko, Kaneko, Akira, Speybroeck, Niko, Kido, Yasutoshi   +6 more
openaire   +3 more sources

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

Bulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi, Babatunde Fagbemi, Taiwo Ibinaiye, Jimmy Aiden, Victor Gabriel, Chrysantus Dabes, Tapshak Kyeshir, Daniel Oguche, Omolola Obayemi, Aminu Biambo, Andrew Okwulu, Adaeze Aidenagbon   +11 more
doaj   +1 more source

Malaria chemoprevention and drug resistance: a review of the literature and policy implications

Malaria Journal, 2022
Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-malarial drugs used for chemoprevention is perennially threatened by drug resistance.
Christopher V. Plowe
doaj   +1 more source

A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda [version 2; peer review: 1 approved, 2 approved with reservations]

Gates Open Research, 2023
Background The World Health Organization (WHO) recommends seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) for children aged 3 to 59 months, living in areas where malaria transmission is highly seasonal ...
Craig Bonnington, Sol Richardson, Godfrey Magumba, Christian Rassi, Jane Nabakooza, Denis Rubahika, Anthony Nuwa, James Tibenderana, Jimmy Opigo, Jane Achan, Richard Kajubi, Kevin Baker, Jennifer Ainsworth   +12 more
doaj   +1 more source

Shifts in the clinical epidemiology of severe malaria after scaling up control strategies in Mali

Frontiers in Neurology, 2022
A decrease in malaria incidence following implementation of control strategies such as use of artemisinin-based combination therapies, insecticide-impregnated nets, intermittent preventive treatment during pregnancy and seasonal malaria chemoprevention ...
Drissa Coulibaly, Abdoulaye K. Kone, Bourama Kane, Bouréima Guindo, Bourama Tangara, Mody Sissoko, Fayçal Maiga, Karim Traore, Aichatou Diawara, Amidou Traore, Ali Thera, Mahamadou S. Sissoko, Ogobara K. Doumbo, Mark A. Travassos, Mahamadou A. Thera   +14 more
doaj   +1 more source

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria [PDF]

BMJ Global Health, 2022
Background In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria.
Monica Anna de Cola, Benoît Sawadogo, Sol Richardson, Taiwo Ibinaiye, Adama Traoré, Cheick Saïd Compaoré, Chibuzo Oguoma, Olusola Oresanya, Gauthier Tougri, Christian Rassi, Arantxa Roca-Feltrer, Patrick Walker, Lucy C Okell   +12 more
openaire   +4 more sources

Seasonal malaria chemoprevention for malaria in children in areas with seasonal malaria

, 2022
This report was considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.3 Seasonal malaria chemoprevention (SMC)” of the WHO Guidelines for malaria, 3 June 2022.
Thwing JI, Williamson J, Cavros I, Bhattarai A, Gutman J   +4 more
openaire   +2 more sources

Combining malaria vaccination with chemoprevention: a promising new approach to malaria control

Malaria Journal, 2021
Malaria control has stalled in a number of African countries and novel approaches to malaria control are needed for these areas. The encouraging results of a recent trial conducted in young children in Burkina Faso and Mali in which a combination of the ...
Brian Greenwood, Matthew Cairns, Mike Chaponda, R. Matthew Chico, Alassane Dicko, Jean-Bosco Ouedraogo, Kamija S. Phiri, Feiko O. ter Kuile, Daniel Chandramohan   +8 more
doaj   +1 more source

Effectiveness of Seasonal Malaria Chemoprevention in children under 10 years of age in Senegal: a stepped-wedge cluster-randomized trial [PDF]

, 2016
This study was done to determine the effectiveness of Seasonal Malaria Chemoprevention in Senegalese children up to 10 years of age using a stepped-wedge design.
Milligan, Paul
core   +2 more sources